Systematic high-throughput combination drug screen to enhance poly (ADP-ribose) polymerase (PARP) inhibitor efficacy in ovarian cancer.Katherine Foster, Anil K. Sood, Reid T. Powell et al.|Journal of Clinical Oncology|2023Cited by 1